Characteristic | Overall | High LCR | Low LCR | p-value |
---|---|---|---|---|
 | N = 2424 | N = 1387 | N = 1037 |  |
Sex, male, n (%) | 1457 (60.1) | 902 (65.0) | 555 (53.5) |  < 0.001 |
Age, years, mean (SD) | 60.18 (11.18) | 62.00 [54.00, 68.00] | 60.00 [52.00, 66.00] |  < 0.001 |
BMI, mean (SD) | 22.09 (3.13) | 21.90 [19.70, 24.10] | 22.30 [20.10, 24.60] | 0.002 |
PGSGA (median [IQR]) | 6.83 (5.12) | 7.00 [4.00, 11.00] | 4.00 [2.00, 8.00] |  < 0.001 |
KPS (median [IQR]) | 82.60 (13.84) | 80.00 [70.00, 90.00] | 90.00 [80.00, 90.00] |  < 0.001 |
TP (median [IQR]) | 68.40 (7.04) | 68.00 [63.05, 73.00] | 69.30 [65.00, 73.40] |  < 0.001 |
Scr (median [IQR]) | 69.89 (33.62) | 65.40 [54.40, 79.00] | 65.75 [55.90, 78.00] | 0.803 |
Alb (median [IQR]) | 38.17 (5.08) | 36.80 [33.35, 40.00] | 40.50 [37.70, 43.00] |  < 0.001 |
Tch (median [IQR]) | 4.63 (1.22) | 4.36 [3.73, 5.14] | 4.66 [4.01, 5.39] |  < 0.001 |
CRP (median [IQR]) | 23.63 (38.74) | 21.30 [9.57, 51.65] | 3.02 [1.31, 3.24] |  < 0.001 |
Glu (median [IQR]) | 5.86 (1.95) | 5.47 [4.86, 6.40] | 5.26 [4.80, 5.97] |  < 0.001 |
Hb (median [IQR]) | 119.85 (29.05) | 120.00 [102.00, 134.00] | 130.00 [115.00, 140.00] |  < 0.001 |
N (median [IQR]) | 4.82 (3.33) | 4.80 [3.40, 6.66] | 3.40 [2.57, 4.64] |  < 0.001 |
L (median [IQR]) | 1.49 (0.82) | 1.25 [0.90, 1.67] | 1.59 [1.24, 1.97] |  < 0.001 |
RBC (median [IQR]) | 6.06 (82.34) | 4.07 [3.58, 4.53] | 4.30 [3.91, 4.69] |  < 0.001 |
PLT (median [IQR]) | 237.93 (98.06) | 239.00 [175.50, 305.00] | 213.00 [168.00, 268.00] |  < 0.001 |
Lung cancer, yes, n (%) | 917 (37.8) | 539 (38.9) | 378 (36.5) |  < 0.001 |
Gastric cancer, yes, n (%) | 276 (11.4) | 155 (11.2) | 121 (11.7) |  < 0.001 |
Liver cancer, yes, n (%) | 92 (3.8) | 63 (4.5) | 29 (2.8) |  < 0.001 |
Breast cancer, yes, n (%) | 136 (5.6) | 53 (3.8) | 83 (8.0) |  < 0.001 |
Esophageal cancer, yes, n (%) | 156 (5.95) | 91 (6.5) | 65 (6.2) |  < 0.001 |
Gynecological tumor, yes, n (%) | 67 (2.8) | 40 (2.9) | 27 (2.6) |  < 0.001 |
Urinary cancer, yes, n (%) | 62 (2.5) | 40 (2.8) | 22 (2.1) |  < 0.001 |
Pancreatic cancer, yes, n (%) | 97 (4.0) | 57 (4.1) | 40 (3.9) |  < 0.001 |
Nasopharyngeal cancer, yes, n (%) | 52 (2.1) | 24 (1.7) | 28 (2.7) |  < 0.001 |
Colorectal cancer, yes, n (%) | 396 (16.3) | 206 (14.9) | 190 (18.3) |  < 0.001 |
Biliary Tract cancer, yes, n (%) | 36 (1.5) | 31 (2.2) | 5 (0.5) |  < 0.001 |
Other cancer, yes, n (%) | 136 (5.6) | 87 (6.3) | 49 (4.7) |  < 0.001 |
Surgery, yes, n (%) | 1492 (61.6) | 923 (66.5) | 569 (54.9) |  < 0.001 |
Radiotherapy, yes, n (%) | 2114 (87.2) | 1203 (86.7) | 911 (87.8) | 0.452 |
Chemotherapy, yes, n (%) | 897 (37.0) | 534 (38.5) | 363 (35.0) | 0.085 |